JAZZ compared with AGCO: revenue, margins and what each company keeps, and the suppliers and customers both name

JAZZJazz Pharmaceuticals plc

Mkt capRevenueRevenue

AGCOAgco Corp

Mkt capRevenueRevenue

Compare

JAZZJazz Pharmaceuticals plc

AGCOAgco Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

JAZZ

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.9%▲+7.13%×0.90

Q2 FY26±6.8%▲+3.99%×0.59

Q1 FY26—▲+7.68%—

Feb 25 '26—▲+13.23%—

AGCO2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.9%▲+5.56%×0.71

Q2 FY26—▼−7.78%—

= impliedJAZZ realized, solidAGCO realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedspan: JAZZ 251d · AGCO 91dSource: market data

JAZZJazz Pharmaceuticals plc

234.74▲+3.26%· post 234.74

Mkt cap$15.1BRevenue$1.2BQ3 FY26Revenue$4.3BFY25

AGCOAgco Corp

110.43▲+0.19%· post 110.43

ClosedNov 6 '26

Mkt cap$7.6BRevenue$2.3BQ3 FY26Revenue$10.1BFY25

Compare

ClosedNov 6 '26

JAZZJazz Pharmaceuticals plc

AGCOAgco Corp

234.74▲+3.26%post 234.74

Price

110.43▲+0.19%post 110.43

$15.1B

Mkt cap

$7.6B

Q3 FY26$1.2B

Revenue

$2.3BQ3 FY26

FY25$4.3B

Revenue

$10.1BFY25

JAZZ234.74▲+3.26%vsAGCO110.43▲+0.19%ClosedNov 6 '26